keyword
interferon
hepat
c
viru
bovin
viral
diarrhea
viru
yellow
fever
viru
hepat
viru
sever
acut
respiratori
syndrom
coronaviru
antivir
innat
immun
interferoninduc
exonucleas
inhibit
replic
sever
human
anim
rna
virus
howev
specif
antivir
action
remain
poorli
defin
determin
impact
ectop
express
replic
sever
positivestrand
rna
virus
distinct
viral
famili
inhibit
infect
cell
culturederiv
hepat
c
viru
hcv
pestiviru
bovin
viral
diarrhea
viru
picornaviru
hepat
viru
moreov
demonstr
celltyp
specif
antivir
activ
yellow
fever
viru
classic
flaviviru
overexpress
howev
inhibit
propag
sever
acut
respiratori
syndrom
coronaviru
highlypathogen
human
coronaviru
cell
antivir
effect
depend
exonucleas
activ
close
relat
cellular
exonucleas
inhibit
hcv
replic
togeth
data
may
help
better
understand
antivir
specif
action
eukaryot
evolv
numer
intrins
mechan
combat
microbi
infect
interferon
ifn
system
major
innat
antivir
pathway
present
vertebr
cell
rapidli
activ
tightli
regul
fashion
respons
viral
infect
viral
nucleic
acid
viral
genom
gener
viral
replic
present
major
pathogen
associ
molecular
pattern
pamp
variou
cellular
pamp
receptor
includ
membran
bound
tolllik
receptor
tlr
cytoplasm
riglik
receptor
rlr
upon
engag
cognat
ligand
tlr
rlr
recruit
distinct
adaptor
protein
transmit
signal
downstream
kinas
culmin
activ
latent
transcript
factor
nfkb
coordin
regul
synthesi
type
ifn
yoneyama
fujita
secret
ifn
act
paracineautocrin
fashion
cell
surfac
ifn
receptor
lead
induct
hundr
ifn
stimul
gene
isg
via
jakstat
pathway
sen
stark
et
al
although
consider
progress
made
understand
biolog
function
number
isg
much
remain
learn
role
major
isg
innat
antivir
defens
apart
induc
cellular
gene
direct
antivir
effect
ifn
also
regul
activ
profession
immun
cell
shape
subsequ
adapt
immun
viru
infect
sen
stark
et
al
yoneyama
fujita
virolog
addit
serv
pamp
activ
ifn
system
viral
nucleic
acid
repres
excel
target
subject
direct
action
cellular
antivir
protein
among
latter
rnase
l
pathway
repres
princip
compon
ifn
antivir
effector
mechan
latent
ubiquit
endonucleas
rnase
l
activ
short
oligoadenyl
produc
ifninduc
synthetas
follow
viral
infect
activ
rnase
l
exert
direct
antivir
effect
cleav
degrad
viral
rna
also
cleav
cellular
rrna
result
inhibit
protein
synthesi
cellular
apoptosi
therebi
prevent
viral
propag
silverman
rnase
ldefici
mice
enhanc
suscept
infect
encephalomyocard
viru
emcv
coxsackieviru
herp
simplex
viru
west
nile
viru
flodstromtullberg
et
al
samuel
et
al
zheng
et
al
zhou
et
al
nevertheless
analys
mice
tripli
defici
three
wellcharacter
antivir
pathway
pkr
rnase
l
mx
demonstr
presenc
altern
effector
mechan
mediat
ifn
antivir
action
zhou
et
al
ifnstimul
gene
kda
protein
recent
emerg
second
ifnregul
rnase
inhibit
rna
viru
replic
degol
et
al
along
close
relat
aka
apoptosisenhanc
nucleas
aen
belong
yeast
rna
exonucleas
homolog
subfamili
within
deddh
exonucleas
famili
cout
et
al
protein
famili
rnase
dnase
activ
larg
structur
relat
long
exonucleas
domain
exoiii
contain
three
distinct
exonucleas
motif
term
exo
exo
ii
exo
iii
defin
four
conserv
acid
amino
acid
dedd
conserv
histidin
residu
degol
et
al
biochem
analys
demonstr
exonucleas
prefer
singlestrand
ss
rna
ssdna
nguyen
et
al
overexpress
vitro
restrict
infect
emcv
vesicular
stomat
viru
influenza
viru
hiv
sindbi
viru
although
antivir
effici
vari
espert
et
al
espert
et
al
zhang
et
al
also
inhibit
replic
subgenom
genotyp
hepat
c
viru
hcv
rna
replicon
cell
mechan
underli
antivir
action
remain
poorli
understood
viral
specif
degol
et
al
former
believ
involv
degrad
viral
rna
mean
exonucleas
activ
although
possibl
action
cellular
factor
exclud
degol
et
al
antivir
action
thought
oper
poorli
doubl
strand
region
rnase
activ
neg
regul
presenc
stemloop
structur
rna
substrat
nguyen
et
al
howev
small
number
rna
virus
test
thu
far
preclud
better
understand
specif
mechan
action
furthermor
known
whether
antivir
effect
share
exonucleas
close
relat
studi
compar
cell
cultur
effect
replic
sever
positivestrand
rna
virus
distinct
viral
famili
includ
flavivirida
hcv
bovin
viral
diarrhea
viru
bvdv
yellow
fever
viru
yfv
piconavirida
hepat
viru
hav
coronavirida
sever
acut
respiratori
syndrom
coronaviru
sarscov
show
inhibit
replic
genotyp
subgenom
hcv
rna
cell
cultur
deriv
hcv
hav
cultur
hepatoma
cell
restrict
bvdv
propag
bovin
kidney
cell
demonstr
celltyp
specif
antivir
effect
yfv
classic
flaviviru
inhibit
sarscov
highli
pathogen
novel
human
coronaviru
cell
antivir
effect
hcv
share
data
character
antivir
activ
distinct
posit
strand
rna
virus
may
help
better
understand
specif
action
ifnmedi
antivir
innat
immun
character
cell
stabli
express
human
relat
catalyt
inact
mutant
determin
affect
hcv
replic
hepatocyt
develop
cell
stabli
express
human
design
control
cell
express
catalyt
inact
mutant
defici
exonucleasa
activ
nguyen
et
al
design
express
empti
vector
design
respect
use
retroviralmedi
gene
transfer
cell
repres
sublin
highli
permiss
hcv
replic
blight
et
al
addit
deriv
cell
suscept
mani
rna
virus
distinct
viral
famili
guix
et
al
hattermann
et
al
keskinen
et
al
lohmann
et
al
muller
et
al
tang
et
al
yi
lemon
establish
cell
stabli
express
abl
evalu
effect
isg
replic
mani
differ
virus
elimin
phenotyp
differ
deriv
variat
among
individu
cell
clone
util
stabl
cell
pool
instead
clonal
cell
line
ectop
express
fig
data
shown
distribut
nucleu
cytoplasm
could
readili
detect
cell
immunoblot
analysi
use
antibodi
direct
either
myc
epitag
introduc
cterminu
fig
upper
panel
protein
lower
panel
control
vector
express
cell
although
stabli
express
high
level
fig
alter
growth
characterist
cell
fig
compar
vs
cell
affect
rigi
signal
defect
cell
sumpter
et
al
determin
absenc
induct
follow
sendai
viru
infect
irrespect
express
statu
fig
compar
lane
vs
ectop
express
cell
inhibit
replic
bicistron
select
subgenom
hcvn
genotyp
rna
replicon
determin
affect
hcv
replic
hepatocyt
first
compar
cell
support
replic
genotyp
rna
construct
monocistron
subgenom
rna
replicon
code
sequenc
hcv
structur
protein
replac
cdna
sequenc
encod
blasticidin
resist
gene
product
directli
fuse
nterminu
renilla
luciferas
fmdv
autoproteas
ubiquitin
latter
two
direct
process
nterminu
fig
rna
rnadepend
rna
polymeras
defect
gnd
mutant
replic
continu
robustli
transfect
cell
express
renilla
luciferas
measur
viral
rna
amplif
data
shown
replic
effici
similar
kinet
cell
reach
plateau
h
posttransfect
fig
contrast
replic
sever
impair
cell
time
point
examin
replic
level
rna
alway
lower
cell
fig
control
gnd
mutant
replicon
fail
replic
three
cell
fig
next
determin
express
affect
propag
viru
agreement
data
replicon
experi
found
infecti
progeni
viru
releas
cultur
supernat
reproduc
lower
cell
cell
h
postinfect
moi
viru
yield
similar
latter
two
cultur
fig
aggreg
inhibit
replic
genotyp
hcv
rna
replicon
cell
also
act
restrict
genotyp
hcv
rna
replic
viru
propag
cultur
hepatocyt
exonucleas
activ
requir
antivir
activ
hcv
antivir
action
thought
involv
degrad
viral
rna
exonucleas
activ
degol
et
al
determin
whether
promot
hcv
rna
degrad
determin
stabil
modifi
subgenom
hcv
rna
encod
luciferas
report
gene
also
contain
lethal
mutat
rnadepend
rna
polymeras
fig
upon
introduct
cell
hcv
rna
express
renilla
firefli
luciferas
direct
hcv
ire
emcv
ire
respect
luciferas
activ
serv
readout
hcv
rna
abund
due
inabl
hcv
rna
replic
decay
rate
luciferas
activ
repres
rate
hcv
rna
degrad
electropor
cell
nonrepl
strain
genotyp
rna
degrad
rapidli
first
h
follow
slow
decay
next
h
luciferas
activ
drop
background
level
appreci
differ
among
cell
fig
similar
result
obtain
replicationincompet
rna
hcvn
strain
genotyp
use
lieu
rna
fig
data
indic
seem
acceler
degrad
transfect
hcv
rna
translat
positivesens
hcv
rna
direct
ire
within
hcv
lead
synthesi
viral
protein
requir
hcv
replic
consid
possibl
may
exert
fig
character
cell
stabli
express
human
catalyt
inact
mutant
immunofluoresc
stain
express
use
antimyc
mab
cell
mocktransfect
upper
panel
transient
transfect
vector
encod
myctag
lower
panel
dapi
stain
nuclei
shown
right
panel
similar
subcellular
local
observ
cell
stabli
transduc
human
mutant
data
shown
b
immunoblot
analysi
express
cell
stabli
express
empti
vector
bsr
probe
antimyc
mab
upper
panel
lower
panel
respect
actin
detect
mab
antiactin
upper
panel
demonstr
equal
sampl
load
note
express
slightli
higher
level
unknown
whether
reflect
autoregul
express
c
realtim
pcr
analysi
mrna
level
cell
mocktreat
stimul
uml
infect
sev
hauml
h
mrna
abund
normal
cellular
rrna
fold
differ
calcul
divid
normal
mrna
abund
follow
variou
treatment
mocktreat
cell
induc
endogen
express
cell
sev
upregul
mrna
cell
triplic
well
cell
plate
cultur
indic
time
period
cell
prolifer
assess
mtt
assay
e
express
reconstitut
rigi
signal
defect
cell
normal
cell
mock
infect
infect
hauml
sev
h
prior
cell
lysi
immunoblot
analysi
sev
use
antimyc
tag
mab
asterisk
panel
denot
nonspecif
band
cell
treat
recombin
human
h
lane
includ
posit
control
express
antivir
effect
inhibit
iresmedi
translat
test
transfect
cell
prlhl
lerat
et
al
dicistron
report
vector
express
renilla
luciferas
capdepend
translat
downstream
firefli
luciferas
code
sequenc
capindepend
control
hcv
ire
fig
shown
fig
capdepend
hcv
iresdepend
translat
effici
compar
among
three
differ
cell
popul
indic
antivir
action
hcv
replic
result
effect
hcv
ire
activ
exhibit
dn
effect
activ
endogen
vsv
infect
hela
cell
espert
et
al
contrast
observ
increas
permiss
viru
rna
replic
fig
infect
fig
compar
cell
lack
dn
effect
like
due
absenc
detect
basal
protein
express
deriv
cell
fig
lower
panel
determin
whether
inhibit
antihcv
activ
ifn
induc
express
pretreat
cell
high
concentr
human
uml
induc
cellular
antivir
state
ifn
remov
cell
transfect
replicon
rna
determin
kinet
intracellular
hcv
rna
replic
fig
absenc
ifn
pretreat
cell
support
robust
hcv
rna
replic
reach
plateau
h
posttransfect
appreci
differ
two
cell
popul
ifn
pretreat
strongli
suppress
rna
replic
cell
substanti
less
effect
cell
cell
h
posttransfect
hcv
rna
replic
reduc
ifn
pretreat
respect
cell
decreas
respect
cell
fig
differ
could
attribut
impair
respons
jakstat
signal
ifn
cell
ifn
induct
two
wellcharacter
isg
mxa
similar
effici
cell
compar
cell
fig
aggreg
data
suggest
signific
contributor
ifn
antivir
action
intracellular
hcv
rna
replic
inhibit
next
determin
affect
ifn
antihcv
action
context
viru
infect
toward
end
pretreat
cell
rang
concentr
uml
induc
cellular
antivir
state
ifn
remov
cell
infect
viru
moi
h
postinfect
cultur
supernat
examin
infecti
progeni
viru
yield
ffu
assay
fig
found
pretreat
cell
low
uml
abl
reduc
infecti
viru
product
obviou
reduct
higher
ifn
concentr
note
reduct
progeni
viru
yield
ifn
pretreat
differ
cell
regardless
ifn
concentr
use
suggest
mediat
inhibit
intracellular
hcv
rna
replic
repres
fraction
ifn
effect
hcv
infect
conceiv
ifn
may
also
target
variou
step
hcv
life
cycl
intracellular
hcv
rna
replic
viral
entri
uncoat
packag
releas
etc
stark
et
al
may
target
exonucleas
activ
antivir
mechan
may
compet
ectop
express
two
close
relat
member
gene
subfamili
within
deddh
exonucleas
famili
cout
et
al
lee
et
al
protein
exoiii
exonucleas
domain
highli
similar
within
ctermin
portion
fig
howev
unlik
compos
exoiii
domain
addit
structur
gene
remov
substitut
blasticidin
deaminas
bla
fusion
gene
follow
foot
mous
diseas
viru
autoproteas
peptid
ubiquitin
direct
process
nterminu
lower
panel
cell
transfect
replicon
rna
harvest
indic
time
point
rluc
assay
data
shown
repres
foldincreas
rluc
activ
present
h
cell
type
repres
least
independ
conduct
experi
b
cell
infect
viru
moi
indic
time
point
cellfre
cultur
supernat
harvest
subject
infecti
viru
titer
determin
fluoresc
focu
form
assay
cell
data
shown
repres
least
two
independ
conduct
experi
ntermin
sequenc
aa
respect
function
ntermin
part
poorli
understood
could
determin
predomin
nuclear
local
two
protein
cout
et
al
lee
et
al
agreement
previou
studi
found
express
exclus
within
nucleu
transfect
cell
resembl
nuclear
bodi
local
pattern
fig
determin
whether
two
protein
antivir
activ
hcv
attempt
establish
cell
stabli
express
respect
use
retrovir
mediat
gene
transfer
abl
gener
stabl
pool
express
fig
howev
effort
obtain
express
cell
unsuccess
thu
farvirtu
cell
surviv
select
process
infect
retrovirus
reason
failur
remain
unclear
could
reflect
cellular
toxic
associ
longterm
ectop
express
fig
except
aa
mutat
gdd
motif
gnd
indic
gdd
motif
delet
indic
translat
firefli
luciferas
ffluc
fmda
autoproteas
downstream
polyprotein
direct
emcv
ire
b
c
cell
transfect
vitro
transcrib
b
c
rna
indic
time
point
post
transfect
cell
lyse
subject
renilla
b
firefli
c
luciferas
activ
assay
hcv
rna
degrad
reflect
percent
decreas
luciferas
activ
normal
h
posttransfect
luciferas
activ
result
translat
initi
input
hcv
rna
schemat
show
organ
bicistron
report
construct
prlhl
cmvie
cmv
immedi
earli
promot
bghpa
bovin
growth
hormon
polyadenyl
signal
e
cell
triplic
well
transfect
prlhl
h
lyse
dual
luciferas
assay
determin
translat
effici
direct
rluc
hcv
ire
ffluc
respect
result
normal
luciferas
activ
transfect
bsr
cell
contrast
impair
replic
abil
cell
replicon
replic
effici
cell
cell
fig
agreement
intracellular
core
protein
accumul
viru
infect
greatli
reduc
cell
compar
cell
compar
latter
two
fig
thu
unlik
antivir
activ
hcv
cultur
hepatoma
cell
unabl
gener
stabl
cell
express
adopt
transient
cotransfect
strategi
determin
effect
hcv
rna
replic
cotransfect
cell
replicon
rna
encod
plasmid
ratio
monitor
hcv
rna
replic
determin
fold
increas
luciferas
activ
h
h
posttransfect
control
cell
cotransfect
replicon
rna
plasmid
posit
control
empti
vector
encod
vector
neg
control
although
strongli
inhibit
replic
compar
empti
vector
fig
togeth
antivir
activ
hcv
share
close
relat
protein
cell
respond
similarli
ifn
cell
treat
uml
h
prior
total
rna
extract
realtim
pcr
analysi
mxa
mrna
express
fold
chang
gene
calcul
normal
data
mock
treat
cell
differ
baselin
mxa
mrna
mocktreat
cell
ident
residu
throughout
three
sequenc
heavi
greyshad
letter
semiident
residu
light
greyshad
letter
five
conserv
amino
acid
residu
e
h
characterist
deddh
exonucleas
superfamili
blackshad
letter
exoiii
domain
amino
acid
ident
respect
b
subcellular
local
transient
transfect
cell
immunostain
green
use
antimyc
mab
nuclei
counterstain
blue
dapi
show
similar
local
pattern
cell
data
shown
c
immunoblot
analysi
use
antimyc
mab
actin
express
lane
lane
cell
replic
kinet
replicon
cell
cell
transfect
analyz
similarli
fig
data
shown
repres
two
independ
conduct
experi
e
cell
infect
viru
moi
indic
time
point
cell
lysat
subject
immunoblot
analysi
hcv
core
actin
express
result
repres
independ
conduct
experi
f
cell
transient
cotransfect
replicon
rna
empti
vector
plasmid
encod
respect
ratio
use
lipofectamin
replic
replicon
determin
calcul
fold
increas
luciferas
activ
h
h
posttransfect
upper
panel
lower
panel
express
protein
analyz
western
blot
use
antimyc
mab
actin
immunoblot
demonstr
equal
sampl
load
classifi
within
genu
pestiviru
famili
flavivirida
bvdv
share
similar
genom
structur
replic
strategi
hcv
wide
use
vitro
surrog
model
system
identif
character
antivir
agent
use
hcv
buckwold
et
al
hcv
cell
cultur
system
becam
avail
sinc
suppress
hcv
rna
replic
ask
question
whether
replic
close
relat
bvdv
also
subject
inhibitori
action
toward
end
establish
mbdk
cell
pool
stabli
express
design
design
control
vector
design
bkbsr
respect
retrovir
mediat
gene
transfer
contrast
control
bkbsr
cell
cell
express
abund
myctag
protein
fig
b
demonstr
cytoplasm
nuclear
local
fig
pattern
similar
observ
human
cell
fig
espert
et
al
espert
et
al
infect
cytopath
bvdv
nadl
viru
rang
increas
moi
cell
substanti
less
cpe
cell
surviv
cell
fig
agreement
progeni
bvdv
yield
infect
cell
consist
lower
bkbsr
cell
h
postinfect
latter
two
similar
moi
shown
fig
conclud
experi
similar
hcv
bvdv
also
sensit
antivir
action
cell
cultur
celltyp
specif
antivir
effect
yfv
infect
next
determin
affect
replic
yfv
prototyp
member
genu
flaviviru
famili
flavivirida
infect
virul
asibi
strain
yfv
moi
three
deriv
cell
support
effici
viru
growth
appreci
differ
infecti
progeni
viru
releas
fig
intracellular
accumul
yfv
antigen
fig
observ
period
regardless
express
statu
result
differ
vaccin
strain
yfv
use
lieu
asibi
strain
infect
fig
thu
contrast
effect
hcv
inhibit
yfv
propag
hepatoma
cell
determin
whether
lack
antivir
activ
yfv
cell
celltyp
specif
phenomenon
took
advantag
flpin
trex
cell
tetregul
condit
express
cell
cultur
induc
tet
repress
express
follow
infect
viru
moi
day
grew
much
slower
rate
cell
fig
celltyp
specif
antivir
effect
yfv
infect
cell
infect
yfv
asibi
strain
moi
panel
b
yfv
strain
moi
panel
c
indic
time
point
cellfre
cultur
supernat
harvest
viral
titer
determin
fluoresc
focusform
assay
panel
c
data
shown
repres
two
independ
conduct
experi
b
immunoblot
analysi
yfv
use
antimyc
antibodi
actin
express
cell
lysat
condit
panel
trex
cell
condit
express
cultur
presenc
absenc
tetracyclin
day
induc
repress
express
respect
subsequ
infect
yfv
viru
moi
day
cellfre
cultur
supernat
harvest
progeni
viral
titer
determin
fluoresc
focusform
assay
panel
cell
lysat
harvest
subject
immunoblot
analysi
yfv
arrow
head
actin
arrow
use
antiflag
antibodi
protein
panel
e
data
shown
repres
two
independ
conduct
experi
cell
progeni
viru
cultur
supernat
first
detect
h
postinfect
fig
found
induct
reduc
progeni
yfv
product
log
h
postinfect
fig
consist
accumul
yfv
antigen
diminish
cell
express
fig
compar
lane
vs
cell
induc
express
fig
compar
lane
vs
collect
although
demonstr
antivir
activ
yfv
cell
potent
inhibit
yfv
replic
cell
effect
depend
catalyt
activ
hav
picornaviru
infect
mainli
hepatocyt
caus
acut
hepat
vivo
martin
lemon
determin
whether
inhibit
hav
replic
first
compar
replic
effici
subgenom
hav
rna
replicon
encod
lucifers
havluc
fig
among
cell
havluc
replic
effici
cell
similar
kinet
result
increas
luciferas
activ
h
follow
plateau
later
contrast
replic
havluc
substanti
compromis
cell
result
lower
luciferas
activ
observ
cell
h
posttransfect
fig
result
suggest
express
restrict
hav
rna
replic
cell
determin
whether
inhibit
hav
replic
context
viru
infect
flpin
trex
cell
tetregul
express
cultur
induc
tet
repress
express
fig
follow
infect
viru
day
induct
associ
reproduc
reduct
progeni
hav
yield
effect
observ
upon
express
fig
collect
inhibit
hav
replic
hepat
nonhepat
cell
antihav
effect
depend
exonucleas
activ
inhibit
propag
sarscov
cell
sarscov
highli
pathogen
human
coronaviru
recogn
unlik
known
human
coronavirus
usual
associ
mild
upper
respiratori
tract
infect
infect
sarscov
caus
sever
lower
respiratori
ill
mortal
rate
peiri
et
al
peiri
et
al
although
specif
antivir
therapi
avail
treatment
sar
ifn
known
inhibit
sarscov
replic
vitro
protect
sarscov
infect
vivo
cinatl
et
al
haagman
et
al
spiegel
et
al
zheng
et
al
sinc
highli
upregul
lung
cynomolgu
macaqu
experiment
infect
sarscov
de
lang
et
al
set
determin
whether
contribut
antivir
action
ifn
sarscov
take
advantag
fact
sarscov
b
replic
kinet
havluc
replicon
cell
data
shown
repres
independ
experi
c
trex
cell
condit
express
cultur
presenc
absenc
tetracyclin
day
induc
repress
express
respect
subsequ
infect
viru
moi
day
cell
lysat
harvest
immunoblot
express
use
antiflag
antibodi
gapdh
panel
c
hav
infecti
viru
yield
determin
infrar
fluoresc
immunofocu
assay
serial
dilut
sampl
cell
panel
panel
control
dish
tet
dilut
stain
secondari
antibodi
conjug
replic
cell
hattermann
et
al
tang
et
al
infect
low
moi
cell
releas
similar
amount
progeni
virus
cultur
medium
time
point
observ
period
fig
consist
intracellular
accumul
sarscov
nucleocapsid
protein
compar
among
cell
popul
regardless
express
statu
fig
data
reveal
inhibit
sarscov
replic
hepatoma
cell
studi
character
antivir
spectrum
vitro
determin
effect
ectop
express
replic
number
distinct
posit
strand
rna
virus
previous
shown
exhibit
antivir
activ
vesicular
stomat
viru
emcv
influenza
viru
hiv
sindbi
viru
espert
et
al
espert
et
al
zhang
et
al
demonstr
current
studi
also
inhibit
hav
bvdv
cell
cultur
deriv
hcv
viru
furthermor
report
exhibit
celltyp
specif
antivir
activ
yfv
infect
fig
demonstr
antiyfv
effect
cell
potent
inhibit
yfv
replic
cell
latter
result
line
recent
report
demonstr
inhibit
infect
two
close
relat
flavivirus
yfv
west
nile
viru
dengu
viru
ectop
express
cell
jiang
et
al
present
know
cellular
factor
contribut
dispar
antiyfv
activ
cell
nonetheless
data
suggest
need
caution
interpret
result
obtain
differ
cell
type
thu
although
observ
antivir
effect
propag
sarscov
cell
fig
studi
need
determin
whether
hold
true
cell
type
support
effici
sarscov
replic
recent
report
inhibit
genotyp
hcvn
strain
subgenom
hcv
rna
replicon
stabli
express
cell
current
studi
show
also
act
inhibit
replic
genotyp
subgenom
replicon
well
propag
cell
culturederiv
hcv
viru
cultur
hepatocyt
furthermor
result
show
ectop
express
inhibit
hcv
rna
replic
progeni
viru
releas
cell
lack
rigi
viral
rna
sens
pathway
recogn
hcv
replic
trigger
ifn
antivir
respons
li
et
al
saito
et
al
sumpter
et
al
wang
et
al
therefor
antivir
action
hcv
infect
seem
depend
ifninduc
factor
contrast
shown
zincfing
antivir
protein
isg
requir
ifninduc
factor
inhibit
alphaviru
virion
product
macdonald
et
al
howev
result
rule
possibl
one
ifnstimul
cellular
factor
may
enhanc
antivir
activ
demonstr
antivir
activ
hcv
hav
bvdv
yfv
requir
exonucleas
activ
consist
abrog
mutat
specif
disrupt
activ
site
exoiii
domain
fig
nguyen
et
al
current
propos
effector
mechan
involv
degrad
viral
rna
exonucleas
activ
degol
et
al
howev
precis
act
inhibit
hcv
hav
yfv
bvdv
infect
known
result
show
enhanc
degrad
transfect
hcv
rna
regardless
viru
strain
genotyp
hcvn
genotyp
test
fig
littl
surpris
possibl
exert
antivir
action
target
cellular
factor
requir
viru
replic
degol
et
al
howev
also
possibl
recogn
hcv
rna
associ
replic
complex
andor
resid
certain
cellular
compart
note
rna
stabil
data
fig
c
replic
defect
rna
henc
gave
inform
whether
promot
degrad
neg
strand
hcv
rna
could
constitut
antivir
mechan
show
affect
hcv
iresmedi
translat
fig
essenti
step
hcv
protein
includ
nonstructur
protein
involv
viral
rna
replic
made
furthermor
demonstr
ectop
express
mutant
suppress
ifn
antivir
effect
replic
subgenom
hcv
rna
hepatoma
cell
fig
indic
critic
compon
execut
ifn
antivir
action
hcv
rna
replic
hepatocyt
conceiv
catalyticallyinact
mutant
may
act
dn
inhibitor
compet
recognizingassoci
viralcellular
substrat
viru
use
probe
ifn
antivir
action
dn
effect
mutant
evid
fig
surpris
ifn
like
target
multipl
stage
hcv
life
cycl
recapitul
hcv
rna
replicon
system
probabl
subject
action
viral
attach
entri
uncoat
packag
egress
etc
repres
two
close
relat
exoribonucleas
cout
et
al
lee
et
al
share
highli
similar
exoiii
domain
amino
acid
ident
compar
respect
biolog
function
two
protein
well
understood
aka
aen
induc
follow
ioniz
radiat
dna
damag
requir
effici
dna
fragment
apoptosi
lee
et
al
involv
ribosom
biogenesi
level
rrna
matur
specif
process
precursor
rrna
cout
et
al
data
analyz
hcv
rna
replic
effici
hepatoma
cell
ectop
express
reveal
antivir
function
two
protein
least
hcv
fig
may
intrins
differ
substrat
prefer
note
local
within
nucleu
fig
cout
et
al
lee
et
al
wherea
distribut
nucleu
cytoplasm
fig
espert
et
al
espert
et
al
possibl
access
hcv
rna
andor
cellular
factor
essenti
hcv
replic
target
mrna
highli
upregul
liver
chimpanze
infect
hcv
follow
intraven
administr
ifn
bigger
et
al
lanford
et
al
liver
chimpanze
acut
infect
hepat
b
viru
hbv
induc
viral
clearanc
stage
wieland
et
al
interestingli
ectop
express
cell
reduc
secret
hb
hbe
antigen
transfect
cell
hao
yang
broad
antivir
activ
multipl
distinct
hepat
virus
hav
hcv
hbv
indic
import
antivir
effector
molecul
downstream
ifn
signal
innat
defens
liver
convent
pcr
techniqu
use
construct
retrovir
express
vector
encod
human
respect
backbon
akagi
et
al
encod
ctermin
tag
human
encod
ctermin
myctag
human
respect
contain
cdna
sequenc
encod
catalyt
inact
mutant
differ
codon
asp
gac
human
convert
gli
ggc
bicistron
report
plasmid
prlhl
subgenom
phavluc
replicon
construct
describ
lerat
et
al
yi
lemon
monocistron
replicon
construct
follow
kindli
provid
c
rice
tschern
et
al
first
modifi
includ
blasticidin
resist
gene
directli
fuse
nterminu
renilla
luciferas
achiev
ecorimlui
fragment
contain
entir
first
corecod
sequenc
replac
similarli
digest
fragment
amplifi
pcr
kindli
provid
g
luo
chang
et
al
use
primer
cagtgaattctaatacgactcactatag
gtcatacgcgtgccctcccacacataac
result
plasmid
name
subsequ
quikchang
sitedirect
mutagenesi
conduct
remov
hcv
code
sequenc
downstream
ubiquitin
sequenc
lead
direct
fusion
nterminu
ubiquitin
result
plasmid
digest
agei
avrii
releas
cdna
fragment
hereaft
refer
fragment
l
contain
partial
first
aa
code
sequenc
core
blasticidin
resist
gene
full
renilla
luciferas
code
sequenc
fmdv
autoproteas
sequenc
ubiquitin
partial
code
sequenc
kato
et
al
kindli
provid
wakita
digest
agei
avrii
remov
partial
first
aa
code
sequenc
core
neomycin
phosphotransferas
ii
gene
emcv
ire
partial
code
sequenc
use
vector
ligat
fragment
l
gener
monocistron
replicon
replic
defect
mutant
replicon
construct
way
except
use
vector
backbon
ligat
fragment
l
fragment
l
construct
fulli
sequenc
confirm
authent
monocistron
replic
defect
mutant
replicon
hcvn
strain
construct
replac
cdna
fragment
contain
neomycin
phosphotransferas
ii
gene
emcv
ire
ikeda
et
al
cdna
cassett
contain
emcv
ire
firefli
luciferas
gene
fmdv
autoproteas
latter
directli
fuse
nterminu
addit
start
codon
core
convert
termin
codon
tag
replicon
rna
prepar
plasmid
dna
templat
linear
xbai
xmai
phavluc
use
megascript
kit
ambion
purifi
dnase
treatment
licl
precipit
rna
quantifi
optic
densiti
qualiti
concentr
confirm
agaros
gel
electrophoresi
human
hepatoma
cell
african
green
monkey
kidney
cell
maintain
convent
techniqu
mdbk
cell
cultur
dulbecco
modifi
eagl
medium
supplement
hors
serum
penicillin
streptomycin
flpin
trex
cell
express
mutant
cultur
describ
mdbk
cell
stabli
express
catalyt
inact
mutant
control
vector
establish
transduc
cell
replic
incompet
retrovirus
encod
wt
mutant
empti
vector
respect
follow
select
blasticidin
invivogen
week
describ
previous
wang
et
al
replicon
rna
transfect
deriv
cell
use
dmriec
transfect
reagent
invitrogen
ratio
lipid
rna
describ
lanford
et
al
dna
transfect
deriv
cell
conduct
use
miru
per
manufactur
instruct
experi
replicon
rna
plasmid
cotransfect
cell
use
lipofectamin
suggest
manufactur
invitrogen
cell
cultur
deriv
hcv
viru
stock
produc
transfect
cell
vitro
transcrib
rna
titrat
ffu
assay
follow
immunostain
hcv
core
describ
wakita
et
al
yi
et
al
cytopath
nadl
strain
bvdv
gift
frolov
bvdv
stock
prepar
mdbk
cell
titrat
assay
urbani
strain
sarscov
provid
lm
hayn
g
ksiazek
center
diseas
control
prevent
atlanta
ga
sarscov
stock
grown
titrat
vero
cell
wildtyp
yfv
asibi
strain
provid
dr
robert
tesh
univers
texa
medic
branch
utmb
galveston
tx
world
refer
collect
emerg
virus
arbovirus
wrceva
vaccin
strain
yfv
deriv
infecti
clone
rice
et
al
provid
dr
alan
barrett
utmb
yfv
stock
grown
cell
atcc
harvest
day
postinfect
cytopath
effect
first
visibl
rapidli
replic
cell
cultureadapt
variant
hav
lemon
et
al
work
stock
produc
cell
experi
involv
virul
yfv
sarscov
conduct
approv
biosafeti
laboratori
utmb
sendai
viru
stock
cantel
strain
purchas
charl
river
laboratori
infecti
progeni
viru
yield
cellfre
cultur
supernat
hcv
yfv
infect
cultur
determin
focu
form
assay
viral
titer
express
ffuml
detail
hcv
ffu
titrat
assay
present
elsewher
wakita
et
al
yi
et
al
titrat
yfv
yield
cell
infect
serial
dilut
time
cours
supernat
sampl
h
co
occasion
rock
follow
overlay
mem
sigma
supplement
bovin
growth
serum
hyclon
plate
incub
day
co
fix
buffer
formalin
sigma
cell
permeabil
ethanol
wash
twice
pb
antiyfv
mous
hyperimmun
ascit
fluid
kindli
provid
robert
tesh
wrceva
pb
solut
contain
milk
tween
sigma
ad
incub
overnight
rock
cell
wash
twice
pb
incub
goat
antimous
igg
hrpconjug
antibodi
dako
solut
pb
supplement
nonsteril
bovin
growth
serum
incub
h
room
temperatur
cell
wash
twice
pb
follow
stain
aec
substrat
chromagen
dako
focu
form
unit
visual
bvdv
sarscov
infecti
progeni
viru
yield
determin
standard
tcid
assay
base
observ
cytopath
effect
mdbk
bvdv
nadl
vero
sarscov
cell
monolay
plate
seri
sampl
describ
titer
express
tcid
ml
titer
infecti
hav
determin
infrar
fluoresc
focu
assay
describ
jangra
et
al
five
million
cell
electropor
vitro
transcrib
rna
use
biorad
genepuls
xcell
system
paramet
use
v
maximum
resist
electropor
cell
cultur
plate
indic
time
period
prior
cell
lysi
duplic
well
passiv
lysi
buffer
promega
measur
renilla
gnd
rna
transfect
cell
firefli
rna
transfect
cell
luciferas
activ
cell
lysat
luciferas
activ
h
post
transfect
set
calcul
percent
luciferas
activ
later
time
point
use
compar
rate
hcv
rna
degrad
follow
indic
treatment
total
cellular
rna
extract
cell
use
trizol
reagent
invitrogen
treat
dnase
remov
genom
dna
contamin
abund
cellular
mrna
specif
human
mxa
gene
determin
quantit
realtim
rtpcr
use
commerci
avail
primer
taqman
probe
appli
biosystem
mrna
quantif
conduct
sybr
greenbas
quantit
realtim
rtpcr
use
primer
cellular
extract
prepar
subject
immunoblot
analysi
describ
li
et
al
b
follow
mab
polyclon
pab
antibodi
use
antiflag
antiactin
mab
sigma
antimyc
tag
mab
cell
signal
tech
mab
abnova
rabbit
antiyfv
pab
charl
rice
rabbit
anticor
pab
john
mclauchlan
antihav
mab
commonwealth
serum
institut
rabbit
pab
wang
et
al
antisendai
viru
pab
ilkka
julkunen
rabbit
antisarscov
n
pab
imgenex
peroxidaseconjug
secondari
goat
antirabbit
goat
antimous
pab
southern
biotech
protein
band
visual
use
enhanc
chemiluminesc
millipor
follow
exposur
xray
film
